RetinalGenix Technologies Inc. (CIK: 0001836295) EDGAR, Information, Filings... CompaniesBIO.Com

RetinalGenix Technologies Inc.

Mailing address
1450 NORTH MCDOWELL BOULEVARD, SUITE 150, PETALUMA, Delaware, 94954
Phone
415-578-9583
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Filings
N/A

RetinalGenix Technologies Inc. (CIK: 0001836295) is an American company incorporated in the state of California. Head office is located at 1450 NORTH MCDOWELL BOULEVARD, SUITE 150, PETALUMA, California, 94954. Work in the industry 3841 - (CF Office: Office of Life Sciences) SURGICAL & MEDICAL INSTRUMENTS & APPARATUS. RetinalGenix Technologies Inc. is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by RetinalGenix Technologies Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001493152-24-020564 (34 Act) Size: 3088 KB	May-20-2024	333-258528 24962772
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001493152-24-020228 (34 Act) Size: 38 KB	May-16-2024	333-258528 24955477
EFFECT	Document	Acc-no: 9999999995-24-001469 (33 Act) Size: 1 KB	May-10-2024	333-258528 24936700
EFFECT	Document	Acc-no: 9999999995-24-001470 (33 Act) Size: 1 KB	May-10-2024	333-262282 24936685
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-24-018132 (33 Act) Size: 4466 KB	May-08-2024	333-262282 24923471
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-24-018130 (33 Act) Size: 4484 KB	May-08-2024	333-258528 24923460
8-K	Document	Current report filing Acc-no: 0001493152-24-013775 (34 Act) Size: 195 KB	Apr-08-2024	333-258528 24829607
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-012185 (34 Act) Size: 4234 KB	Apr-01-2024	333-258528 24806032
EFFECT	Document	Acc-no: 9999999995-24-000380 (33 Act) Size: 1 KB	Feb-12-2024	333-262282 24622408
EFFECT	Document	Acc-no: 9999999995-24-000378 (33 Act) Size: 1 KB	Feb-12-2024	333-258528 24622403
D	Document	Acc-no: 0001493152-24-005749 (33 Act) Size: 10 KB	Feb-09-2024	021-504938 24616093
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-24-005520 ( Act) Size: 20 KB	Feb-08-2024
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-24-005518 ( Act) Size: 20 KB	Feb-08-2024
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-24-005156 (33 Act) Size: 5865 KB	Feb-06-2024	333-258528 24601362
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-000706 (33 Act) Size: 5 KB	Feb-05-2024	333-258528 24596652
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-24-002804 (33 Act) Size: 5838 KB	Jan-18-2024	333-258528 24539663
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-24-002806 ( Act) Size: 56 KB	Jan-17-2024
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-23-046609 ( Act) Size: 41 KB	Dec-29-2023
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001493152-23-046606 (33 Act) Size: 6024 KB	Dec-29-2023	333-262282 231528285
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-23-046600 ( Act) Size: 72 KB	Dec-29-2023

Recent 20 filings. View all RetinalGenix Technologies Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

RetinalGenix Technologies Inc. overview
RetinalGenix Technologies Inc. job
RetinalGenix Technologies Inc. stock
RetinalGenix Technologies Inc. ownership
RetinalGenix Technologies Inc. CEO
RetinalGenix Technologies Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.